ObjectivesRespiratory failure, multiple organ failure, shortness of breath, recovery, and mortality have been identified as critically important core outcomes by more than 9300 patients, health professionals, and the public from 111 countries in the global coronavirus disease 2019 core outcome set initiative. The aim of this project was to establish the core outcome measures for these domains for trials in coronavirus disease 2019.DesignThree online consensus workshops were convened to establish outcome measures for the four core domains of respiratory failure, multiple organ failure, shortness of breath, and recovery.SettingInternational.PatientsAbout 130 participants (patients, public, and health professionals) from 17 countries attended ...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...
(1) Objective: The World Health Organization’s (WHO) International Classification of Functioning, Di...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortalit...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortali...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortal...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortalit...
Objectives: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous ...
OBJECTIVES: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous ...
Objective: The outcomes reported in trials in COVID-19 are extremely heterogeneous and of uncertain ...
Since its outbreak in December 2019, a series of clinical trials on Coronavirus Disease 2019 (COVID-...
OBJECTIVES: There are over 4,000 trials conducted in people with coronavirus disease 2019. However, ...
Objectives: There are over 4,000 trials conducted in people with coronavirus disease 2019. However,...
International audienceObjectives: There are over 4,000 trials conducted in people with coronavirus d...
OBJECTIVES: To describe the outcomes of hospitalized patients in a multicenter, international corona...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...
(1) Objective: The World Health Organization’s (WHO) International Classification of Functioning, Di...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortalit...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortali...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortal...
OBJECTIVES: Respiratory failure, multiple organ failure, shortness of breath, recovery, and mortalit...
Objectives: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous ...
OBJECTIVES: The outcomes reported in trials in coronavirus disease 2019 are extremely heterogeneous ...
Objective: The outcomes reported in trials in COVID-19 are extremely heterogeneous and of uncertain ...
Since its outbreak in December 2019, a series of clinical trials on Coronavirus Disease 2019 (COVID-...
OBJECTIVES: There are over 4,000 trials conducted in people with coronavirus disease 2019. However, ...
Objectives: There are over 4,000 trials conducted in people with coronavirus disease 2019. However,...
International audienceObjectives: There are over 4,000 trials conducted in people with coronavirus d...
OBJECTIVES: To describe the outcomes of hospitalized patients in a multicenter, international corona...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...
(1) Objective: The World Health Organization’s (WHO) International Classification of Functioning, Di...
Health consequences that persist beyond the acute infection phase of COVID-19, termed post-COVID-19 ...